{"DataElement":{"publicId":"2663836","version":"1","preferredName":"Breast Tumor Post Neoadjuvant Therapy Pathology N Stage","preferredDefinition":"the post-neoadjuvant therapy pathologic N stage for a breast tumor, the extent of lymph node involvement of a malignant neoplasm of the breast based on pathologic examination of the tumor or specimen using the TMN staging system following treatment designed to be used as a first step toward shrinking the cancer and in evaluating response to drugs and other agents. Induction therapy is followed by additional therapy to eliminate whatever cancer remains.","longName":"BRS_TUM_P_NEO_P_N_ST","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"2663817","version":"1","preferredName":"Breast Tumor Post Neoadjuvant Therapy Pathology N Stage","preferredDefinition":"information related to post-neoadjuvant therapy pathologic N stage for a breast tumor, the extent of lymph node involvement of a malignant neoplasm of the breast based on pathologic examination of the tumor or specimen using the TMN staging system following treatment designed to be used as a first step toward shrinking the cancer and in evaluating response to drugs and other agents. Induction therapy is followed by additional therapy to eliminate whatever cancer remains.","longName":"BRST_TUM_P_NEOAD_P_N","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2206465","version":"1","preferredName":"Breast Neoplasm","preferredDefinition":"One of two hemispheric projections of variable size situated in the subcutaneous layer over the pectoralis major muscle on either side of the chest.:(NEE-o-PLAY-zha) Abnormal and uncontrolled cell growth.","longName":"C12971:C3262","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast","conceptCode":"C12971","definition":"One of two hemispheric projections of variable size situated in the subcutaneous layer over the pectoralis major muscle on either side of the chest.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0428-F64A-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"ONEDATA","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2663815","version":"1","preferredName":"Post Neoadjuvant Therapy Pathology N Stage","preferredDefinition":"Post; occuring after.:Treatment designed to be used as a first step toward shrinking the cancer and in evaluating response to drugs and other agents. Induction therapy is followed by additional therapy to eliminate whatever cancer remains.:A specialty concerned with the nature and cause of disease as expressed by changes in cellular or tissue structure and function caused by the disease process. (MSH98):One criteria of the TMN staging system. N refers to the extent of lymph node involvement.","longName":"C38008:C15665:C18189:C25580","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Post","conceptCode":"C38008","definition":"Happening at a time subsequent to a reference time; later in time or order.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Neoadjuvant Therapy","conceptCode":"C15665","definition":"Therapy administered prior to the primary treatment for the purpose of making the primary treatment more effective.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Pathology","conceptCode":"C18189","definition":"The medical science, and specialty practice, concerned with all aspects of disease, but with special reference to the essential nature, causes, and development of abnormal conditions, as well as the structural and functional changes that result from the disease processes. Informally used to mean the result of such an examination.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"N Category","conceptCode":"C25580","definition":"One criteria of the TNM staging system. N refers to the extent of lymph node involvement.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"34FF0F9A-39A6-4A1E-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-07-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-07-11","modifiedBy":"ONEDATA","dateModified":"2007-07-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"34FF0F9A-39B7-4A1E-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-07-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-07-11","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2663828","version":"1","preferredName":"Breast Tumor Post Neoadjuvant Pathologic N Stage","preferredDefinition":"the post-neoadjuvant pathologic N (nodal) stage of a breast tumor, as defined by the AJCC Cancer Staging Manual, 6th Ed.","longName":"BRS_TUM_P_NEO_P_N_ST","context":"CTEP","contextVersion":"2.31","type":"Enumerated","dataType":"CHARACTER","minLength":"4","maxLength":"10","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"ypN1","valueDescription":"Metastasis in 1 to 3 axillary lymph nodes, and/or in internal mammary nodes with microscopic disease detected by SLN dissection but not clinically apparent","ValueMeaning":{"publicId":"2576662","version":"1","preferredName":"Metastasis in 1 to 3 axillary lymph nodes, and/or in internal mammary nodes with microscopic disease detected by SLN dissection but not clinically apparent","longName":"2576662","preferredDefinition":"Metastasis in 1 to 3 axillary lymph nodes, and/or in internal mammary nodes with microscopic disease detected by SLN dissection but not clinically apparent. [Note: Not clinically apparent is defined as not detected by imaging studies (excluding lymphoscintigraphy) or by clinical examination.]","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-F883-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-10-21","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-10-21","modifiedBy":"CAMPBELB","dateModified":"2005-10-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"34FF5505-5B63-5552-E044-0003BA3F9857","beginDate":"2002-02-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-07-11","modifiedBy":"CAMPBELB","dateModified":"2007-07-11","deletedIndicator":"No"},{"value":"ypN1a","valueDescription":"Metastasis in 1 to 3 axillary lymph nodes","ValueMeaning":{"publicId":"2576664","version":"1","preferredName":"Metastasis in 1 to 3 axillary lymph nodes","longName":"2576664","preferredDefinition":"Metastasis in 1 to 3 axillary lymph nodes","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-F885-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-10-21","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-10-21","modifiedBy":"CAMPBELB","dateModified":"2005-10-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"34FF5505-5B6F-5552-E044-0003BA3F9857","beginDate":"2005-10-21","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-07-11","modifiedBy":"CAMPBELB","dateModified":"2007-07-11","deletedIndicator":"No"},{"value":"ypN1b","valueDescription":"Metastasis in internal mammary nodes with microscopic disease detected by SLN dissection but not clinically apparent","ValueMeaning":{"publicId":"2576665","version":"1","preferredName":"Metastasis in internal mammary nodes with microscopic disease detected by SLN dissection but not clinically apparent","longName":"2576665","preferredDefinition":"Metastasis in internal mammary nodes with microscopic disease detected by SLN dissection but not clinically apparent [Note: Not clinically apparent is defined as not detected by imaging studies (excluding lymphoscintigraphy) or by clinical examination.]","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-F886-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-10-21","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-10-21","modifiedBy":"CAMPBELB","dateModified":"2005-10-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"34FF5505-5B7B-5552-E044-0003BA3F9857","beginDate":"2005-10-21","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-07-11","modifiedBy":"CAMPBELB","dateModified":"2007-07-11","deletedIndicator":"No"},{"value":"ypN1c","valueDescription":"Metastasis in 1 to 3 axillary lymph nodes and in internal mammary lymph nodes with microscopic disease detected by SLN dissection but not clinically apparent.","ValueMeaning":{"publicId":"2576666","version":"1","preferredName":"Metastasis in 1 to 3 axillary lymph nodes and in internal mammary lymph nodes with microscopic disease detected by SLN dissection but not clinically apparent.","longName":"2576666","preferredDefinition":"Metastasis in 1 to 3 axillary lymph nodes and in internal mammary lymph nodes with microscopic disease detected by SLN dissection but not clinically apparent. (If associated with >3 positive axillary lymph nodes, the internal mammary nodes are classified as pN3b to reflect increased tumor burden.)[Note: Not clinically apparent is defined as not detected by imaging studies (excluding lymphoscintigraphy) or by clinical examination.]","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-F887-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-10-21","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-10-21","modifiedBy":"CAMPBELB","dateModified":"2005-10-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"34FF5505-5B87-5552-E044-0003BA3F9857","beginDate":"2005-10-21","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-07-11","modifiedBy":"CAMPBELB","dateModified":"2007-07-11","deletedIndicator":"No"},{"value":"ypN1mi","valueDescription":"Micrometastasis (>0.2 mm but <=2.0 mm)","ValueMeaning":{"publicId":"2576663","version":"1","preferredName":"Micrometastasis (>0.2 mm but <=2.0 mm)","longName":"2576663","preferredDefinition":"Micrometastasis (>0.2 mm but <=2.0 mm)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-F884-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-10-21","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-10-21","modifiedBy":"CAMPBELB","dateModified":"2005-10-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"34FF5505-5B93-5552-E044-0003BA3F9857","beginDate":"2005-10-21","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-07-11","modifiedBy":"CAMPBELB","dateModified":"2007-07-11","deletedIndicator":"No"},{"value":"ypN2","valueDescription":"Metastasis in 4 to 9 axillary lymph nodes, or in clinically apparent ** internal mammary lymph nodes in the absence of axillary lymph node metastasis to ipsilateral axillary lymph node(s) fixed to each other or to other structures","ValueMeaning":{"publicId":"2576667","version":"1","preferredName":"Metastasis in 4 to 9 axillary lymph nodes, or in clinically apparent ** internal mammary lymph nodes in the absence of axillary lymph node metastasis to ipsilateral axillary lymph node(s) fixed to each other or to other structures","longName":"2576667","preferredDefinition":"Metastasis in 4 to 9 axillary lymph nodes, or in clinically apparent ** internal mammary lymph nodes in the absence of axillary lymph node metastasis to ipsilateral axillary lymph node(s) fixed to each other or to other structures ** [Note: Not clinically apparent is defined as not detected by imaging studies (excluding lymphoscintigraphy) or by clinical examination.]","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-F888-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-10-21","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-10-21","modifiedBy":"CAMPBELB","dateModified":"2005-10-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"34FF5505-5B9F-5552-E044-0003BA3F9857","beginDate":"2002-02-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-07-11","modifiedBy":"CAMPBELB","dateModified":"2007-07-11","deletedIndicator":"No"},{"value":"ypN2a","valueDescription":"Metastasis in 4 to 9 axillary lymph nodes (at least 1 tumor deposit >2.0 mm)","ValueMeaning":{"publicId":"2576669","version":"1","preferredName":"Metastasis in 4 to 9 axillary lymph nodes (at least 1 tumor deposit >2.0 mm)","longName":"2576669","preferredDefinition":"Metastasis in 4 to 9 axillary lymph nodes (at least 1 tumor deposit >2.0 mm)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-F88A-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-10-21","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-10-21","modifiedBy":"CAMPBELB","dateModified":"2005-10-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"34FF5505-5BAB-5552-E044-0003BA3F9857","beginDate":"2005-10-21","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-07-11","modifiedBy":"CAMPBELB","dateModified":"2007-07-11","deletedIndicator":"No"},{"value":"ypN2b","valueDescription":"Metastasis in clinically apparent* internal mammary lymph nodes in the absence of axillary lymph node metastasis","ValueMeaning":{"publicId":"2576670","version":"1","preferredName":"Metastasis in clinically apparent* internal mammary lymph nodes in the absence of axillary lymph node metastasis","longName":"2576670","preferredDefinition":"Metastasis in clinically apparent* internal mammary lymph nodes in the absence of axillary lymph node metastasis\r\n* [Note: Clinically apparent is defined as detected by imaging studies (excluding lymphoscintigraphy) or by clinical examination.]","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-F88B-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-10-21","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-10-21","modifiedBy":"CAMPBELB","dateModified":"2005-10-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"34FF5505-5BB7-5552-E044-0003BA3F9857","beginDate":"2005-10-21","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-07-11","modifiedBy":"CAMPBELB","dateModified":"2007-07-11","deletedIndicator":"No"},{"value":"ypN3","valueDescription":"Metastasis in >= axillary lymph nodes, or in infraclavicular lymph nodes, or in clinically apparent* ipsilateral internal mammary lymph node(s) in the presence of 1 or more positive axillary lymph node(s); or, in >3 axillary lymph nodes with clinically n","ValueMeaning":{"publicId":"2576668","version":"1","preferredName":"Metastasis in >= axillary lymph nodes, or in infraclavicular lymph nodes, or in clinically apparent* ipsilateral internal mammary lymph node(s) in the presence of 1 or more positive axillary lymph node(s); or, in >3 axillary lymph nodes with clinically n","longName":"2576668","preferredDefinition":"Metastasis in >= axillary lymph nodes, or in infraclavicular lymph nodes, or in clinically apparent* ipsilateral internal mammary lymph node(s) in the presence of 1 or more positive axillary lymph node(s); or, in >3 axillary lymph nodes with clinically negative microscopic metastasis in internal mammary lymph nodes; or, in ipsilateral supraclavicular lymph nodes * [Note: Clinically apparent is defined as detected by imaging studies (excluding lymphoscintigraphy) or by clinical examination.]","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-F889-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-10-21","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-10-21","modifiedBy":"CAMPBELB","dateModified":"2005-10-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"34FF5505-5BC3-5552-E044-0003BA3F9857","beginDate":"2002-02-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-07-11","modifiedBy":"CAMPBELB","dateModified":"2007-07-11","deletedIndicator":"No"},{"value":"ypN3a","valueDescription":"Metastasis in >=10 axillary lymph nodes (at least 1 tumor deposit >2.0 mm); or, metastasis to the infraclavicular lymph nodes","ValueMeaning":{"publicId":"2576673","version":"1","preferredName":"Metastasis in >=10 axillary lymph nodes (at least 1 tumor deposit >2.0 mm); or, metastasis to the infraclavicular lymph nodes","longName":"2576673","preferredDefinition":"Metastasis in >=10 axillary lymph nodes (at least 1 tumor deposit >2.0 mm); or, metastasis to the infraclavicular lymph nodes","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-F88E-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-10-21","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-10-21","modifiedBy":"CAMPBELB","dateModified":"2005-10-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"34FF5505-5BCF-5552-E044-0003BA3F9857","beginDate":"2005-10-21","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-07-11","modifiedBy":"CAMPBELB","dateModified":"2007-07-11","deletedIndicator":"No"},{"value":"ypN3b","valueDescription":"Metastasis in clinically apparent* ipsilateral internal mammary lymph nodes in the presence of >=1 positive axillary lymph node(s); or, in >3 axillary lymph nodes and in internal mammary lymph nodes with microscopic disease detected by sentinel lymph node","ValueMeaning":{"publicId":"2576672","version":"1","preferredName":"Metastasis in clinically apparent* ipsilateral internal mammary lymph nodes in the presence of >=1 positive axillary lymph node(s); or, in >3 axillary lymph nodes and in internal mammary lymph nodes with microscopic disease detected by sentinel lymph node","longName":"2576672","preferredDefinition":"Metastasis in clinically apparent* ipsilateral internal mammary lymph nodes in the presence of >=1 positive axillary lymph node(s); or, in >3 axillary lymph nodes and in internal mammary lymph nodes with microscopic disease detected by sentinel lymph node dissection but not clinically apparent** * [Note: Clinically apparent is defined as detected by imaging studies (excluding lymphoscintigraphy) or by clinical examination.]\r\n** [Note: Not clinically apparent is defined as not detected by imaging studies (excluding lymphoscintigraphy) or by clinical examination.]","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-F88D-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-10-21","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-10-21","modifiedBy":"CAMPBELB","dateModified":"2005-10-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"34FF5505-5BDB-5552-E044-0003BA3F9857","beginDate":"2005-10-21","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-07-11","modifiedBy":"CAMPBELB","dateModified":"2007-07-11","deletedIndicator":"No"},{"value":"ypN3c","valueDescription":"Metastasis in ipsilateral supraclavicular lymph nodes","ValueMeaning":{"publicId":"2576671","version":"1","preferredName":"Metastasis in ipsilateral supraclavicular lymph nodes","longName":"2576671","preferredDefinition":"Metastasis in ipsilateral supraclavicular lymph nodes","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-F88C-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-10-21","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-10-21","modifiedBy":"CAMPBELB","dateModified":"2005-10-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"34FF5505-5BE7-5552-E044-0003BA3F9857","beginDate":"2005-10-21","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-07-11","modifiedBy":"CAMPBELB","dateModified":"2007-07-11","deletedIndicator":"No"},{"value":"ypNX","valueDescription":"Regional lymph nodes cannot be assessed (e.g., not removed for pathologic study or previously removed)","ValueMeaning":{"publicId":"2576656","version":"1","preferredName":"Regional lymph nodes cannot be assessed (e.g., not removed for pathologic study or previously removed)","longName":"2576656","preferredDefinition":"Regional lymph nodes cannot be assessed (e.g., not removed for pathologic study or previously removed)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-F87D-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-10-21","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-10-21","modifiedBy":"CAMPBELB","dateModified":"2005-10-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"34FF5505-5BF3-5552-E044-0003BA3F9857","beginDate":"2002-02-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-07-11","modifiedBy":"CAMPBELB","dateModified":"2007-07-11","deletedIndicator":"No"},{"value":"ypN0","valueDescription":"No regional lymph node metastasis histologically, no additional examination for isolated tumor cells (ITC)","ValueMeaning":{"publicId":"2576657","version":"1","preferredName":"No regional lymph node metastasis histologically, no additional examination for isolated tumor cells (ITC)","longName":"2576657","preferredDefinition":"No regional lymph node metastasis histologically, no additional examination for isolated tumor cells (ITC) Note: ITCs are defined as single tumor cells or small cell clusters !U0.2 mm, usually detected only by immunohistochemical (IHC) or molecular methods but that may be verified on hematoloxylin & eosin (H&E) stains. ITCs do not usually show evidence of malignant activity, e.g., proliferation or stromal reaction.]","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-F87E-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-10-21","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-10-21","modifiedBy":"CAMPBELB","dateModified":"2005-10-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"34FF5505-5B27-5552-E044-0003BA3F9857","beginDate":"2002-02-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-07-11","modifiedBy":"CAMPBELB","dateModified":"2007-07-11","deletedIndicator":"No"},{"value":"ypN0(i+)","valueDescription":"No regional lymph node metastasis histologically, positive IHC, no IHC cluster >0.2 mm","ValueMeaning":{"publicId":"2576659","version":"1","preferredName":"No regional lymph node metastasis histologically, positive IHC, no IHC cluster >0.2 mm","longName":"2576659","preferredDefinition":"No regional lymph node metastasis histologically, positive IHC, no IHC cluster >0.2 mm","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-F880-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-10-21","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-10-21","modifiedBy":"CAMPBELB","dateModified":"2005-10-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"34FF5505-5B33-5552-E044-0003BA3F9857","beginDate":"2005-10-21","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-07-11","modifiedBy":"CAMPBELB","dateModified":"2007-07-11","deletedIndicator":"No"},{"value":"ypN0(i-)","valueDescription":"No regional lymph node metastasis histologically, negative IHC","ValueMeaning":{"publicId":"2576658","version":"1","preferredName":"No regional lymph node metastasis histologically, negative IHC","longName":"2576658","preferredDefinition":"No regional lymph node metastasis histologically, negative IHC","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-F87F-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-10-21","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-10-21","modifiedBy":"CAMPBELB","dateModified":"2005-10-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"34FF5505-5B3F-5552-E044-0003BA3F9857","beginDate":"2005-10-21","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-07-11","modifiedBy":"CAMPBELB","dateModified":"2007-07-11","deletedIndicator":"No"},{"value":"ypN0(mol+)","valueDescription":"No regionally lymph node metastasis histologically, positive molecular findings (RT-PCR)","ValueMeaning":{"publicId":"2576661","version":"1","preferredName":"No regionally lymph node metastasis histologically, positive molecular findings (RT-PCR)","longName":"2576661","preferredDefinition":"No regionally lymph node metastasis histologically, positive molecular findings (RT-PCR) [Note: RT-PCR: reverse transcriptase/polymerase chain reaction.]","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-F882-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-10-21","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-10-21","modifiedBy":"CAMPBELB","dateModified":"2005-10-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"34FF5505-5B4B-5552-E044-0003BA3F9857","beginDate":"2005-10-21","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-07-11","modifiedBy":"CAMPBELB","dateModified":"2007-07-11","deletedIndicator":"No"},{"value":"ypN0(mol-)","valueDescription":"No regional lymph node metastasis histologically, negative molecular findings (RT-PCR)","ValueMeaning":{"publicId":"2576660","version":"1","preferredName":"No regional lymph node metastasis histologically, negative molecular findings (RT-PCR)","longName":"2576660","preferredDefinition":"No regional lymph node metastasis histologically, negative molecular findings (RT-PCR) [Note: RT-PCR: reverse transcriptase/polymerase chain reaction.]","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-F881-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-10-21","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-10-21","modifiedBy":"CAMPBELB","dateModified":"2005-10-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"34FF5505-5B57-5552-E044-0003BA3F9857","beginDate":"2005-10-21","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-07-11","modifiedBy":"CAMPBELB","dateModified":"2007-07-11","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2428501","version":"1","preferredName":"Stage","preferredDefinition":"The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body.","longName":"C16899","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Neoplasm Stage","conceptCode":"C16899","definition":"The extent of a cancer in the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"053C2A34-089B-693F-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-11","endDate":null,"createdBy":"ALAIS","dateCreated":"2005-11-11","modifiedBy":"ONEDATA","dateModified":"2005-11-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"34FF5500-DDAF-551E-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-07-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-07-11","modifiedBy":"SBR","dateModified":"2008-12-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008589","version":"2","longName":"Type of Category","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2812156","version":"1","longName":"Breast Cancer DataMart","context":"CTEP"}]},{"publicId":"2956164","version":"1","longName":"Transcend","context":"NCIP","ClassificationSchemeItems":[{"publicId":"2956165","version":"1","longName":"Transcend CDEs","context":"NCIP"}]},{"publicId":"3461586","version":"1","longName":"BOLD:Breast Oncology Local Disease","context":"NCIP","ClassificationSchemeItems":[{"publicId":"3461587","version":"1","longName":"Preoperative Elements","context":"NCIP"}]},{"publicId":"3886755","version":"1","longName":"Preoperative Elements","context":"BOLD","ClassificationSchemeItems":[{"publicId":"3902140","version":"1","longName":"Preoperative","context":"BOLD"}]}],"AlternateNames":[{"name":"caBIG","type":"USED_BY","context":"NCIP"},{"name":"BOLD","type":"USED_BY","context":"BOLD"}],"ReferenceDocuments":[{"name":"Pathologic N Stage","type":"Preferred Question Text","description":"Pathologic N Stage","url":null,"context":"CTEP"},{"name":"DCP CRF TEXT 1","type":"Alternate Question Text","description":"Pathologic N Stage (Post Neoadjuvant)","url":null,"context":"DCP"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"34FF8B14-64DC-194D-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-07-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-07-11","modifiedBy":"MMADDINENI","dateModified":"2023-01-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}